 | • レポートコード：GIR-107A12123 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、神経性過食症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。神経性過食症治療の種類別市場規模（薬物治療、心理治療、栄養療法、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・神経性過食症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、AstraZeneca、Allergan、Pfizer、Bristol-Myers Squibb、Johnson&Johnson、GlaxoSmithKline ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：薬物治療、心理治療、栄養療法、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・神経性過食症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・神経性過食症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・神経性過食症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・神経性過食症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・神経性過食症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bulimia Nervosa Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bulimia Nervosa Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Bulimia Nervosa Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Bulimia Nervosa Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Drug Treatment
Psychological Treatment
Nutrition Therapy
Others
Market segment by Application, can be divided into
Hospitals
Clinic
Others
Market segment by players, this report covers
Eli Lilly
AstraZeneca
Allergan
Pfizer
Bristol-Myers Squibb
Johnson&Johnson
GlaxoSmithKline
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Bulimia Nervosa Treatment
1.2 Classification of Bulimia Nervosa Treatment by Type
1.2.1 Overview: Global Bulimia Nervosa Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Bulimia Nervosa Treatment Revenue Market Share by Type in 2020
1.2.3 Drug Treatment
1.2.4 Psychological Treatment
1.2.5 Nutrition Therapy
1.2.6 Others
1.3 Global Bulimia Nervosa Treatment Market by Application
1.3.1 Overview: Global Bulimia Nervosa Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Bulimia Nervosa Treatment Market Size & Forecast
1.5 Global Bulimia Nervosa Treatment Market Size and Forecast by Region
1.5.1 Global Bulimia Nervosa Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Bulimia Nervosa Treatment Market Size by Region, (2016-2021)
1.5.3 North America Bulimia Nervosa Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Bulimia Nervosa Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Bulimia Nervosa Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Bulimia Nervosa Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Bulimia Nervosa Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Bulimia Nervosa Treatment Market Drivers
1.6.2 Bulimia Nervosa Treatment Market Restraints
1.6.3 Bulimia Nervosa Treatment Trends Analysis
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Bulimia Nervosa Treatment Product and Solutions
2.1.4 Eli Lilly Bulimia Nervosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Bulimia Nervosa Treatment Product and Solutions
2.2.4 AstraZeneca Bulimia Nervosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan Bulimia Nervosa Treatment Product and Solutions
2.3.4 Allergan Bulimia Nervosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Allergan Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Bulimia Nervosa Treatment Product and Solutions
2.4.4 Pfizer Bulimia Nervosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Bulimia Nervosa Treatment Product and Solutions
2.5.4 Bristol-Myers Squibb Bulimia Nervosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.6 Johnson&Johnson
2.6.1 Johnson&Johnson Details
2.6.2 Johnson&Johnson Major Business
2.6.3 Johnson&Johnson Bulimia Nervosa Treatment Product and Solutions
2.6.4 Johnson&Johnson Bulimia Nervosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Johnson&Johnson Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Bulimia Nervosa Treatment Product and Solutions
2.7.4 GlaxoSmithKline Bulimia Nervosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Bulimia Nervosa Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Bulimia Nervosa Treatment Players Market Share
3.2.2 Top 10 Bulimia Nervosa Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Bulimia Nervosa Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Bulimia Nervosa Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Bulimia Nervosa Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Bulimia Nervosa Treatment Revenue Market Share by Application (2016-2021)
5.2 Bulimia Nervosa Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Bulimia Nervosa Treatment Revenue by Type (2016-2026)
6.2 North America Bulimia Nervosa Treatment Revenue by Application (2016-2026)
6.3 North America Bulimia Nervosa Treatment Market Size by Country
6.3.1 North America Bulimia Nervosa Treatment Revenue by Country (2016-2026)
6.3.2 United States Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Bulimia Nervosa Treatment Revenue by Type (2016-2026)
7.2 Europe Bulimia Nervosa Treatment Revenue by Application (2016-2026)
7.3 Europe Bulimia Nervosa Treatment Market Size by Country
7.3.1 Europe Bulimia Nervosa Treatment Revenue by Country (2016-2026)
7.3.2 Germany Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
7.3.3 France Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Bulimia Nervosa Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Bulimia Nervosa Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Bulimia Nervosa Treatment Market Size by Region
8.3.1 Asia-Pacific Bulimia Nervosa Treatment Revenue by Region (2016-2026)
8.3.2 China Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
8.3.5 India Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Bulimia Nervosa Treatment Revenue by Type (2016-2026)
9.2 South America Bulimia Nervosa Treatment Revenue by Application (2016-2026)
9.3 South America Bulimia Nervosa Treatment Market Size by Country
9.3.1 South America Bulimia Nervosa Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Bulimia Nervosa Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Bulimia Nervosa Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Bulimia Nervosa Treatment Market Size by Country
10.3.1 Middle East & Africa Bulimia Nervosa Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Bulimia Nervosa Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Bulimia Nervosa Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Bulimia Nervosa Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Bulimia Nervosa Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Bulimia Nervosa Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Bulimia Nervosa Treatment Revenue Market Share by Region (2021-2026)
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Bulimia Nervosa Treatment Product and Solutions
Table 9. Eli Lilly Bulimia Nervosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca Bulimia Nervosa Treatment Product and Solutions
Table 13. AstraZeneca Bulimia Nervosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Allergan Corporate Information, Head Office, and Major Competitors
Table 15. Allergan Major Business
Table 16. Allergan Bulimia Nervosa Treatment Product and Solutions
Table 17. Allergan Bulimia Nervosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Bulimia Nervosa Treatment Product and Solutions
Table 21. Pfizer Bulimia Nervosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 23. Bristol-Myers Squibb Major Business
Table 24. Bristol-Myers Squibb Bulimia Nervosa Treatment Product and Solutions
Table 25. Bristol-Myers Squibb Bulimia Nervosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Johnson&Johnson Corporate Information, Head Office, and Major Competitors
Table 27. Johnson&Johnson Major Business
Table 28. Johnson&Johnson Bulimia Nervosa Treatment Product and Solutions
Table 29. Johnson&Johnson Bulimia Nervosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline Major Business
Table 32. GlaxoSmithKline Bulimia Nervosa Treatment Product and Solutions
Table 33. GlaxoSmithKline Bulimia Nervosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Bulimia Nervosa Treatment Revenue (USD Million) by Players (2019-2021)
Table 35. Global Bulimia Nervosa Treatment Revenue Share by Players (2019-2021)
Table 36. Breakdown of Bulimia Nervosa Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Bulimia Nervosa Treatment Players Head Office, Products and Services Provided
Table 38. Bulimia Nervosa Treatment Mergers & Acquisitions in the Past Five Years
Table 39. Bulimia Nervosa Treatment New Entrants and Expansion Plans
Table 40. Global Bulimia Nervosa Treatment Revenue (USD Million) by Type (2016-2021)
Table 41. Global Bulimia Nervosa Treatment Revenue Share by Type (2016-2021)
Table 42. Global Bulimia Nervosa Treatment Revenue Forecast by Type (2021-2026)
Table 43. Global Bulimia Nervosa Treatment Revenue by Application (2016-2021)
Table 44. Global Bulimia Nervosa Treatment Revenue Forecast by Application (2021-2026)
Table 45. North America Bulimia Nervosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Bulimia Nervosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Bulimia Nervosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Bulimia Nervosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Bulimia Nervosa Treatment Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Bulimia Nervosa Treatment Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Bulimia Nervosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Bulimia Nervosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Bulimia Nervosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Bulimia Nervosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Bulimia Nervosa Treatment Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Bulimia Nervosa Treatment Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Bulimia Nervosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Bulimia Nervosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Bulimia Nervosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Bulimia Nervosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Bulimia Nervosa Treatment Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Bulimia Nervosa Treatment Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Bulimia Nervosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Bulimia Nervosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Bulimia Nervosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Bulimia Nervosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Bulimia Nervosa Treatment Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Bulimia Nervosa Treatment Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Bulimia Nervosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Bulimia Nervosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Bulimia Nervosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Bulimia Nervosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Bulimia Nervosa Treatment Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Bulimia Nervosa Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Bulimia Nervosa Treatment Picture
Figure 2. Global Bulimia Nervosa Treatment Revenue Market Share by Type in 2020
Figure 3. Drug Treatment
Figure 4. Psychological Treatment
Figure 5. Nutrition Therapy
Figure 6. Others
Figure 7. Bulimia Nervosa Treatment Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Bulimia Nervosa Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Bulimia Nervosa Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Bulimia Nervosa Treatment Revenue Market Share by Region (2016-2026)
Figure 14. Global Bulimia Nervosa Treatment Revenue Market Share by Region in 2020
Figure 15. North America Bulimia Nervosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Bulimia Nervosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Bulimia Nervosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Bulimia Nervosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Bulimia Nervosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Bulimia Nervosa Treatment Market Drivers
Figure 21. Bulimia Nervosa Treatment Market Restraints
Figure 22. Bulimia Nervosa Treatment Market Trends
Figure 23. Eli Lilly Recent Developments and Future Plans
Figure 24. AstraZeneca Recent Developments and Future Plans
Figure 25. Allergan Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 28. Johnson&Johnson Recent Developments and Future Plans
Figure 29. GlaxoSmithKline Recent Developments and Future Plans
Figure 30. Global Bulimia Nervosa Treatment Revenue Share by Players in 2020
Figure 31. Bulimia Nervosa Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Bulimia Nervosa Treatment Revenue Market Share in 2020
Figure 33. Global Top 10 Players Bulimia Nervosa Treatment Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Bulimia Nervosa Treatment Revenue Share by Type in 2020
Figure 36. Global Bulimia Nervosa Treatment Market Share Forecast by Type (2021-2026)
Figure 37. Global Bulimia Nervosa Treatment Revenue Share by Application in 2020
Figure 38. Global Bulimia Nervosa Treatment Market Share Forecast by Application (2021-2026)
Figure 39. North America Bulimia Nervosa Treatment Sales Market Share by Type (2016-2026)
Figure 40. North America Bulimia Nervosa Treatment Sales Market Share by Application (2016-2026)
Figure 41. North America Bulimia Nervosa Treatment Revenue Market Share by Country (2016-2026)
Figure 42. United States Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Bulimia Nervosa Treatment Sales Market Share by Type (2016-2026)
Figure 46. Europe Bulimia Nervosa Treatment Sales Market Share by Application (2016-2026)
Figure 47. Europe Bulimia Nervosa Treatment Revenue Market Share by Country (2016-2026)
Figure 48. Germany Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Bulimia Nervosa Treatment Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Bulimia Nervosa Treatment Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Bulimia Nervosa Treatment Revenue Market Share by Region (2016-2026)
Figure 56. China Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Bulimia Nervosa Treatment Sales Market Share by Type (2016-2026)
Figure 63. South America Bulimia Nervosa Treatment Sales Market Share by Application (2016-2026)
Figure 64. South America Bulimia Nervosa Treatment Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Bulimia Nervosa Treatment Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Bulimia Nervosa Treatment Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Bulimia Nervosa Treatment Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Bulimia Nervosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の薬物中毒治療市場 2021：企業別、地域別、種類・用途別 The Drug Addiction Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界の多汗症治療市場 2021：企業別、地域別、種類・用途別 The Hyperhidrosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の脳性麻痺治療市場 2021：企業別、地域別、種類・用途別 The Cerebral Palsy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のダンピング症候群治療市場 2021：企業別、地域別、種類・用途別 The Dumping Syndrome Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界のレイノー病治療市場 2021：企業別、地域別、種類・用途別 The Raynauds Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…